Log in
NASDAQ:APLS

Apellis Pharmaceuticals Price Target, Predictions & Analyst Ratings

$47.85
+2.42 (+5.33 %)
(As of 11/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$45.66
Now: $47.85
$49.36
50-Day Range
$30.79
MA: $36.16
$45.43
52-Week Range
$16.85
Now: $47.85
$49.36
Volume1.13 million shs
Average Volume976,116 shs
Market Capitalization$3.62 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.12

Analyst Ratings

Apellis Pharmaceuticals (NASDAQ:APLS) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
18 Wall Street analysts have issued ratings and price targets for Apellis Pharmaceuticals in the last 12 months. Their average twelve-month price target is $52.65, predicting that the stock has a possible upside of 10.03%. The high price target for APLS is $86.00 and the low price target for APLS is $29.00. There are currently 5 hold ratings, 12 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
APLS Consensus Rating: BuyBuyBuyBuy
APLS Consensus Rating Score: 2.782.752.732.75
APLS Analyst Ratings: 0 Sell Rating(s)
5 Hold Rating(s)
12 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
10 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
9 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
7 Buy Rating(s)
1 Strong Buy Rating(s)
APLS Consensus Price Target: $52.65$50.14$50.92$52.58
APLS Price Target Upside: 10.03% upside62.23% upside63.05% upside65.32% upside

Apellis Pharmaceuticals (NASDAQ:APLS) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Apellis Pharmaceuticals (NASDAQ:APLS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/23/2020Smith Barney CitigroupBoost Price Target$53.00 ➝ $67.00Low
11/23/2020Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price TargetBuy$53.00 ➝ $67.00High
11/19/2020Needham & Company LLCInitiated CoverageBuy$59.00Low
10/9/2020Cantor FitzgeraldReiterated RatingOverweightLow
8/31/2020Stifel NicolausInitiated CoverageBuy$40.00High
7/20/2020Roth CapitalInitiated CoverageBuy$50.00High
6/16/2020BTIG ResearchInitiated CoverageNeutralHigh
6/12/2020OppenheimerReiterated RatingBuy$62.00High
6/8/2020JPMorgan Chase & Co.Boost Price TargetOverweight$54.00 ➝ $56.00High
5/28/2020UBS GroupInitiated CoverageAddMedium
3/31/2020Raymond JamesInitiated CoverageStrong-Buy$86.00High
3/31/2020BMO Capital MarketsInitiated CoverageOutperform$54.00High
3/11/2020WedbushUpgradeUnderperform ➝ Neutral$29.00High
3/2/2020Credit Suisse GroupLower Price TargetNeutral$36.00 ➝ $34.00High
2/28/2020CowenReiterated RatingBuy$40.00High
1/7/2020SVB LeerinkInitiated CoverageMarket Perform$30.00High
1/7/2020Robert W. BairdReiterated RatingOutperform ➝ Overweight$45.00 ➝ $70.00High
12/19/2019Bank of AmericaInitiated CoverageBuy$36.00High
1/8/2019B. RileyInitiated CoverageBuy$40.00Low
12/4/2017Evercore ISIInitiated CoverageOutperformHigh
(Data available from 11/24/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 11/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.